PolyPeptide Group AG (0AAJ)
LSE
Real-time Data
07:00 AM
Day's Range
43.9552 wk Range
21.95Overview - 0AAJ - PolyPeptide Group AG
Key Statistics
Valuation
Enterprise Value
1.44B
P/E (Trailing)
‪0.29‬
Price / Book
‪4.41‬
EV / EBITDA
‪20.42‬
Profitability
Profit Margin
‪3.14%‬
Operating Margin
‪9.28%‬
Return on Assets
‪3.37%‬
Return on Equity
‪4.23%‬
Ownership
Shares Outstanding
108.05M
Float
12.96M
Held by Insiders
‪60.52%‬
Held by Institutions
‪15.30%‬
Price stats
Beta
‪1.00‬
50-Day Avg
‪16.23‬
200-Day Avg
‪18.82‬
Peers - 0AAJ - PolyPeptide Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0AAJLSEPolyPeptide Group AG+54.34%52-week change0.30P/E (Trailing)‪-5.43%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB+35.36%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR+49.95%52-week change29.67P/E (Trailing)‪51.78%‬Profit Margin
- 0A5VLSEViatris Inc.+35.37%52-week change10.73P/E (Trailing)‪11.88%‬Profit Margin
- 0APMLSEDanieli & C. Officine Meccaniche S.p.A.+35.03%52-week change0.38P/E (Trailing)‪5.73%‬Profit Margin
- CRDLLSECordel Group Plc+49.39%52-week change-6500.00P/E (Trailing)‪-27.15%‬Profit Margin
- SEMGLSEAmundi MSCI Semiconductors UCITS ETF Acc+43.58%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 0AAJ - PolyPeptide Group AG
About
PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). Established with roots dating back to 1952 in Malmö, Sweden, it supports pharmaceutical and biotech companies by providing comprehensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
